Clinical Trial Update: An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg) [Phase 2]

View source ↗

Summary

Phase 2 trial results for DFN-02 (sumatriptan nasal spray 10 mg) assessing efficacy and safety in migraine headaches; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• DFN-02

Snippet

Sponsor: Upsher-Smith Laboratories | Conditions: Migraine Headaches | Phase 2 | Status: COMPLETED | Results posted: 2021-03-30